Skip to main content
. 2018 Nov 9;38:171–177. doi: 10.1016/j.ebiom.2018.11.001

Table 2.

Carrier frequencies for rare variants found in the study.

Control n = 46 Severe HTG n = 103 Subgroup 1 n = 58 Subgroup 2 n = 45
LPL 0(0) 9(8·7) 4(6·9)+ 5(11·1)#
LMF1 2(4·3) 11(10·7) 6(10·3) 5(11·1)
GPIHBP1 2(4·3) 2(1·9) 1(1·7) 1(2·2)
APOA5 0(0) 7(6·8) 3(5·2) 4(8·9)#
GCKR 2(4·3) 8(7·8) 4(6·9) 4(8·9)
CETP 0 1(1·0) 1(1·7) 0
TRIB1 0 3(2·9) 2(3·4) 1(2·2)
APOE 1(2·2) 4(3·9) 1(1·7) 3(6·7)
APOB 7(15·2) 15(14·6) 9(15·5) 6(13·3)
APOA4 1(2·2) 2(1·9) 1(1.7) 1(2·2)
APOA1 0 2(1·9) 0 2(4·4)
ANGPTL3 0 2(1·9) 1(1·7) 1(2·2)
LPL molecular regulating variant 4(8·7) 26(25·2) 13(22·4) 13(28·9)#
APOA1/C3/A4/A5 variant 1(2·2) 10(9·7) 3(5·2) 7(15·6)
≥1 variant in all sequenced genes 12(26·1) 46(44·7) 26(44·8)+ 20(44·4)

p < 0.05 for statically significant difference between control group and Severe HTG group.

+

p < 0.05 for statically significant difference between control group and subgroup 1 (5·65 ≤ TG < 11·30 mmol/L).

#

p < 0.05 for statically significant difference between control group and subgroup 2(TG ≥ 11·30 mmol/L).